The Hidden Arithmetic of Healthcare Scale: Why More Members and Clinics Are Not Enough

What if the most important measure of scale in healthcare is not how many members you insure or how many clinics you own, but how many decisions you can coordinate between them?

That question becomes difficult to ignore when two apparently different stories are placed side by side. One healthcare company can report nearly $42.3 billion in quarterly revenue, more than 32 million commercial members, and a 6.5 percent increase in operating profit. Another can build a network by acquiring more than 240 eye care practices in three years and aim for 275 locations.

At first glance, these are simply stories about growth. One is an insurer expanding its membership base. The other is a practice group expanding its physical footprint. But the deeper pattern is more interesting: healthcare scale creates value only when it improves coordination, not merely when it increases quantity.

That distinction separates a powerful healthcare platform from an expensive collection of assets.

The First Illusion of Scale: More Is Not the Same as Better

Healthcare companies often present scale through easily counted units: members, locations, clinicians, premiums, or acquisitions. These numbers matter, but they are incomplete. They describe the size of a system without telling us whether the system is becoming more intelligent.

Consider the membership figures. Commercial membership rose from 31.625 million to 32.341 million, an increase of 716,000 people. At the same time, Medicaid membership fell from 11.889 million to 9.327 million, a decline of 2.562 million. Medicare Advantage membership also declined by 36,000, while Medicare Supplement membership declined by 29,000.

The headline might be that membership shifted. The more consequential interpretation is that the economic composition of the business changed. The company did not simply gain or lose customers. It gained one kind of relationship while losing others, each with different pricing, utilization, regulatory exposure, and care management requirements.

Revenue grew only 0.9 percent, from $41.9 billion to $42.3 billion. Yet operating profit grew 6.5 percent, from $2.83 billion to $3.02 billion. That is a useful reminder that growth in healthcare is not one-dimensional. A company can grow profit while revenue barely moves if its membership mix, pricing, medical cost management, or operating model improves.

The numbers also imply a modest improvement in operating margin. Operating profit as a share of revenue rose from roughly 6.8 percent to roughly 7.1 percent. Meanwhile, the loss ratio declined from 85.8 percent to 85.6 percent. The improvement is small in percentage terms, but applied to tens of billions of dollars, tiny changes become economically meaningful.

There is a counterpoint. Expenses rose from 19.8 percent to 20.6 percent of revenue. In other words, the company was not creating profit simply by cutting every cost. It appears to have been absorbing higher operating intensity while still improving the relationship between premium revenue and benefit expense.

The lesson is not that efficiency always means spending less. It is that the right spending can make a complex network more profitable.

Scale is not the number of assets under one name. Scale is the ability to make those assets behave like one system.

The Second Illusion of Scale: A Network Is Not Yet a Platform

The eye care example offers a physical version of the same problem. A group acquired and integrated more than 240 optometry and ophthalmology practices over three years, with a goal of reaching 275 locations.

The striking word is not “acquired.” It is “integrated.” Acquisition creates ownership. Integration creates an operating model.

A collection of 275 clinics can remain a fragmented collection of local businesses. Each site may use different systems, negotiate separately with suppliers, schedule patients in its own way, maintain inconsistent clinical protocols, and hold data that cannot easily be compared with data from neighboring practices. In that case, the organization has purchased scale without fully obtaining the benefits of scale.

A genuine platform does something more demanding. It preserves local clinical judgment while standardizing the invisible infrastructure around it. It may centralize billing, recruiting, purchasing, technology, compliance, marketing, payer contracting, and performance measurement. It may use the network to route patients to the right level of care, coordinate referrals, increase specialist utilization, and identify where capacity is sitting idle.

The difference can be illustrated with a simple analogy. Imagine buying 275 restaurants. You would not create a successful restaurant company merely by placing the same logo above every door. You would need a common supply chain, reliable financial controls, training systems, quality standards, demand forecasting, and a way to share what one location learns with all the others.

Healthcare is harder because the product is not a meal. It is a clinical relationship delivered under uncertainty, with ethical obligations and highly variable patient needs. Standardization can improve operations, but excessive standardization can also damage care. The central management challenge is therefore not uniformity. It is selective standardization: standardize what should be repeatable, and protect what requires professional judgment.

This is where the insurer and the provider network begin to resemble one another. The insurer manages a distributed network of members, providers, benefits, and payments. The eye care group manages a distributed network of clinicians, locations, patient flows, and services. Both are trying to reduce friction across many local interactions.

The company with the larger footprint does not automatically win. The winner is more likely to be the one that can convert dispersed activity into shared learning.

The Hidden Asset Is the Interface Between Organizations

The most valuable resource in healthcare may not be the clinic, the insurance contract, or even the patient relationship in isolation. It may be the interface between them.

An interface is where two parts of a system exchange information and make decisions. In healthcare, interfaces include:

• The moment an insurer decides which provider a member should see.
• The handoff from an optometrist to an ophthalmologist.
• The exchange between a clinical diagnosis and a billing code.
• The transition from a benefit design to a patient’s actual treatment choice.
• The movement of data from one location into a network wide operating dashboard.

Poor interfaces create waste that is difficult to see. A patient repeats a test because records are unavailable. A specialist appointment goes unused because referral scheduling breaks down. A clinic keeps excess staff on hand because demand cannot be forecast. An insurer pays for avoidable care because it cannot identify a pattern early enough.

Better interfaces create value without requiring a dramatic breakthrough in medicine. They make existing resources more productive.

This helps explain why a provider segment could show operating profit growth of 9.7 percent, from $741 million to $813 million, while the health benefits segment grew operating profit by 6.4 percent, from $2.15 billion to $2.29 billion. The figures do not prove that integration caused the difference, and they describe different businesses. Still, they point toward a strategic possibility: owning or controlling more of the care delivery interface can make the economics of the whole system more visible and more manageable.

The same logic applies to a growing eye care network. A clinic acquisition is strategically valuable when it gives the broader organization better access to patients, clinical capacity, data, referral pathways, or purchasing leverage. Location count is only a proxy. The real question is what new capability becomes possible because the location is now connected to the rest of the network.

A useful test is this:

If a newly acquired location disappeared tomorrow, would the organization lose only its local revenue, or would it also lose information, referrals, capacity, and strategic reach?

If the answer is only local revenue, the company may own an asset. If the answer includes network effects, it may be building a platform.

Growth Is a Portfolio Decision, Not a Scoreboard

The membership changes also reveal why healthcare leaders should stop treating growth as a single scoreboard.

A million new members can be less attractive than 100,000 new members if the former require substantially more medical spending, administrative complexity, or capital. Conversely, a declining membership category may still be strategically valuable if it improves focus, reduces volatility, or frees resources for a more durable business.

This does not mean that shrinking membership is automatically healthy. It means that volume must be interpreted through the economics and capabilities attached to it.

A practical way to analyze growth is to divide it into four layers:

1. Volume growth: Are there more members, locations, clinicians, or visits?
2. Economic growth: Does each unit produce better contribution after direct costs?
3. Capability growth: Does the organization gain data, expertise, access, or bargaining power?
4. Coordination growth: Do the new units make the existing network more productive?

The first layer is the easiest to report and the easiest to misunderstand. The fourth is usually the hardest to achieve and the most defensible when achieved.

For example, a new clinic may produce revenue immediately. But its larger value could emerge later if it improves geographic coverage, supplies specialists to nearby primary care sites, fills unused surgical capacity, or creates a denser patient base for centralized services. Similarly, a new insurance member may be profitable not only because of the premium attached to that member, but because better data from the member improves risk prediction or care management for thousands of others.

This is why a network should be evaluated as a learning system. Each transaction should answer three questions:

• What did we add?
• What did the addition teach us?
• How quickly can that learning improve the rest of the network?

If the answer to the third question is “not at all,” the organization is accumulating, not compounding.

A Better Operating Model: The Three Clocks of Healthcare Scale

Healthcare organizations often fail because they measure one clock while the business is governed by three.

The first is the transaction clock. It records acquisitions, enrollment, contracts, revenue, and reported earnings. This is the clock most visible to investors and executives.

The second is the integration clock. It records how long it takes to unify technology, workflows, incentives, clinical standards, and reporting. This clock is slower and less glamorous. It is also where much of the promised value is either created or destroyed.

The third is the trust clock. It records how quickly clinicians, patients, payers, and employees come to believe that the new system will improve their work rather than simply extract more from it. Trust cannot be acquired through a purchase agreement. It must be earned through consistent behavior.

These clocks can move at different speeds. An organization can acquire dozens of practices in a year while integration remains incomplete. It can add members faster than its care management systems can handle them. It can report immediate financial gains while weakening the relationships needed for long term performance.

The most disciplined operators synchronize the clocks. They do not ask only how fast they can buy or enroll. They ask whether the organization can absorb the next unit without reducing service quality, clinician autonomy, data integrity, or managerial attention.

One useful metric is integration yield:

Integration yield = measurable network benefit divided by acquired or added units

The benefit might include lower avoidable utilization, improved appointment access, greater specialist capacity, lower administrative cost, stronger retention, or better clinical outcomes. The exact measure will vary, but the principle is stable. Every new unit should create some benefit beyond its standalone economics.

Another useful metric is coordination density: the number and quality of productive connections among members, providers, locations, and services. A network with 275 poorly connected clinics may be less valuable than a network with 100 clinics that share data, referrals, protocols, and incentives.

These metrics redirect attention from the visible architecture of scale to its functional architecture.

Key Takeaways

• Separate quantity from coordination. Track members, locations, and revenue, but also measure referral completion, data sharing, capacity utilization, care transitions, and the time required to integrate new units.
• Analyze growth by mix. A change in membership or locations is not meaningful until you understand the economics, regulatory exposure, clinical needs, and strategic capabilities associated with each category.
• Standardize the infrastructure, not every clinical decision. Centralize repeatable administrative and operational processes while preserving the professional judgment that makes care trustworthy.
• Demand a network effect from every expansion. Before acquiring or launching a new unit, specify what it will improve for the units already in the system.
• Measure the three clocks. Review transaction results immediately, integration progress over time, and trust signals continuously. Fast growth with slow integration is often deferred failure.

The future of healthcare competition will not be decided only by who has the most members or the largest provider directory. It will be decided by who can make a complicated ecosystem easier to navigate without reducing it to a machine.

That is the paradox of scale. Expansion creates the possibility of coordination, but it also creates more opportunities for fragmentation. A company can become larger while becoming less coherent. It can own more clinics while knowing less about what happens inside them. It can serve more members while delivering a more disconnected experience.

The real strategic asset, then, is not size. It is organized interdependence: a system in which each new member, clinic, clinician, and data point makes the others more useful.

When healthcare leaders learn to measure that kind of scale, growth stops being a contest to accumulate units. It becomes a discipline of turning relationships into capability, and capability into better care.